AbbVie Inc.

ABBV · NYSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$4$5$12$12
Dep. & Amort.$8$9$8$9
Deferred Tax-$1-$3-$2-$1
Stock-Based Comp.$1$1$1$1
Change in WC-$3$3-$0-$1
Other Non-Cash$9$9$6$4
Operating Cash Flow$19$23$25$23
Investing Activities
PP&E Inv.-$1-$1-$1-$1
Net Acquisitions-$17-$1-$1-$2
Inv. Purchases-$0-$0-$1-$0
Inv. Sales/Matur.$1$0$2$0
Other Inv. Act.-$3$0$1$0
Investing Cash Flow-$21-$2-$1-$2
Financing Activities
Debt Repay.$7-$4-$12-$8
Stock Issued$0$0$0$0
Stock Repurch.-$2-$2-$1-$1
Dividends Paid-$11-$11-$10-$9
Other Fin. Act.$0-$1-$1-$0
Financing Cash Flow-$5-$17-$25-$19
Forex Effect-$0$0-$0-$0
Net Chg. in Cash-$7$4-$1$1
Supplemental Information
Beg. Cash$13$9$10$8
End Cash$6$13$9$10
Free Cash Flow$18$22$24$22